Related by context. All words. (Click for frequent words.) 57 Quinamed 56 RESTORE CLI 56 ANTEGREN 55 MEND CABG 55 Harry Palmin President 54 SABCS 53 ENDEAVOR III 53 Aplidin 53 CRLX# 53 CAMPATH 53 Aggressive Reduction 52 ASCO GU 52 Late Breaker 52 EVEREST II 52 evaluating mipomersen 52 ASCO abstract 52 Phase Ib clinical 52 Pediatric Oncology Branch 52 Ultrafast Insulin 52 Nasdaq IDRA today 52 PRECISE trial 52 Anti Tumor 52 randomized Phase 2b 52 MEND CABG II 52 ZYBRESTAT TM 51 phase IIb study 51 midstage clinical 51 ICAAC IDSA 51 phase 2a 51 Dr. Scangos 51 Carfilzomib 51 phase IIIb 51 HuMax EGFr 51 Demonstrates Potent 50 fosbretabulin 50 preclinical efficacy 50 evaluating carfilzomib 50 BiTE Antibody 50 Phase 2b RESTORE CLI 50 Diabetic Macular Edema DME 50 Cloretazine R 50 BiTE antibody MT# 50 velafermin 50 neratinib 50 TAXUS ATLAS 50 HORIZONS AMI trial 50 ELACYT 50 ASCO GI 49 Renal Cell Cancer 49 PERSEUS 49 ON #.Na 49 AVADO 49 GW# [003] 49 ISEL 49 Inflammatory Arthritis 49 CHAMPION PCI 49 rALLy 49 #th Annual Interscience 49 assessing T DM1 49 Morbidity Mortality 49 AACR NCI EORTC 49 AASLD Meeting 49 cabozantinib 49 HCV Protease Inhibitor 49 Celgene Revlimid 49 Cholesterol Levels SPARCL 49 BCIRG 48 Phase #/#a trial 48 Showed Significant 48 CLARITY study 48 JNJ Q2 48 ASCO Annual Meeting 48 Phase 1b 48 zanolimumab 48 NanoKnife IRE System 48 prospective multicentre 48 CALGB 48 FDA Pulmonary Allergy 48 demonstrated clinically meaningful 48 teriflunomide 48 ILLUMINATE 48 Onyx Pharmaceuticals ONXX 48 Society CTOS 48 ARBITER 6 48 Unusual Options 48 Data Suggest 48 CYT# potent vascular disrupting 48 Shows Promising 48 evaluating bavituximab 48 CALGB # [002] 48 lintuzumab 48 viral kinetic 48 Chemotherapy Improves 48 Glufosfamide 47 Breaking Clinical Trials 47 BARI 2D 47 ACRIN 47 #th Interscience Conference 47 Connective Tissue Oncology 47 CARE HF 47 TG MV 47 multicenter randomized Phase 47 ASGT 47 Noteworthy Trading 47 ACCLAIM II 47 Zemplar Capsules 47 Antisoma AS# 47 GOUT 47 ARISE Phase III 47 BiovaxID Phase 47 oral ridaforolimus 47 Dr. Pingpank 47 sunitinib malate 47 Romidepsin 47 ECASS 47 Telik Announces 47 AVAiL 47 Study Shows Significant 46 pertuzumab 46 RE LY 46 MERLIN TIMI 46 Opexa 46 dose escalation clinical 46 PARTNER Trial 46 PROTECT AF 46 EORTC NCI AACR Symposium 46 MERIT ES 46 HCV SPRINT 46 OMAPRO 46 ToGA 46 Dr. McHutchison 46 CAPRA 46 initiate Phase 2b 46 ARQL 46 USpella 46 CTRC AACR San Antonio 46 multicenter randomized controlled 46 Chemophase 46 subanalysis 46 AACR #st Annual Meeting 46 Acadia Pharmaceuticals ACAD 46 Castration Resistant Prostate Cancer 46 AACR #nd Annual Meeting 46 registrational 46 AVN# Phase 46 AACR IASLC Joint 46 AVERROES 46 omacetaxine mepesuccinate 46 Digestive Diseases Week 46 TRANSFORMS 46 Hematological Cancers 46 ZEVALIN ® 45 HORIZONS AMI 45 ASH Annual Meeting 45 ECTRIMS 45 AASLD 45 Pharmacoeconomic 45 Statistically Significant Improvement 45 Dr. Agarwala 45 International Nasdaq PRAI 45 multicenter prospective 45 SPIRIT FIRST 45 Midday Unusual Options 45 entitled Treatment Algorithms 45 relapsed MCL 45 recurrent glioblastoma multiforme 45 Breast Cancer Symposium 45 nucleoside tide 45 Idiopathic Pulmonary Fibrosis 45 CABANA 45 Ariad Pharmaceuticals ARIA 45 ONCOLOGY 45 Solid Tumor 44 Gastrointestinal Cancers Symposium 44 iSBTc 44 Phase III Psoriasis 44 ARBITER 44 IMGN 44 SWOG 44 lumiliximab 44 Daniel Junius 44 metaanalysis 44 Summarizes 44 haematological malignancies 44 Genitourinary Cancers Symposium 44 ASCO Genitourinary Cancers Symposium 44 Outcome Measures 44 pharmacodynamic PD 44 visceral metastases 44 Idenix Pharmaceuticals 44 ASCO Breast Cancer 44 entinostat 44 clinical 44 ECCMID 44 AUA Annual Meeting 44 ACCORD Lipid 43 Introgen Therapeutics Inc. 43 endoscopic remission 43 Rheumatology ACR Annual 43 Unusual Trading 43 Curon Medical 43 Recurrent Chest Wall 43 ASSERT 43 Attention Deficit Hyper 43 Shire plc SHPGY 43 RE LY trial 43 AVI BioPharma Announces 43 Initiate Phase II 43 Analysis Comparative Analysis 43 HBeAg + 43 Transcatheter Cardiovascular Therapeutics TCT 43 Dose Reduction 43 Acute Myeloid Leukaemia AML 43 riociguat 43 Restanza TM 43 Protease Inhibitor 43 varespladib 43 Radiation Therapy Oncology 43 Genvec 43 Daxor 43 IN PATIENTS WITH 43 Cashflow Report 43 MATCHED 43 CELLO 43 EASL 43 Prostate Cancer Symposium 43 Solorel TM 43 EINSTEIN DVT 43 CLOTS 43 APTIVUS R 43 INTEGRILIN R eptifibatide Injection 43 Angiolix 43 RIO Lipids 43 DDW ® 43 Activity 43 STEEPLE 43 Amorcyte 42 REALITY Trial 42 ICAAC 42 Multiple Myeloma MM 42 ExTRACT TIMI 42 Remodeling Activity 42 CLL8 42 Sustained Reduction 42 AvalonBay Communities Announces 42 Screening Trial DMIST 42 ASCO 42 BHIVA 42 MTAX CTIC 42 Study Underscores 42 oral FTY# 42 EORTC 42 Extends Collaboration 42 Guidelines Issued 42 pharmacokinetic pharmacodynamic 42 Nasdaq ENZN 42 Hematology Annual Meeting 42 Removab 42 Gynecological Cancer 42 FDA APPROVES 42 JACI 42 Betaferon R 42 Protein Structure 42 Cardiac Outcomes 42 APTIMA HPV assay 42 ARRY 42 AIM HIGH 42 ZEAL 42 Anti Angiogenesis 42 Commercial Leading Indicator 42 ASBMR 42 Theravance THRX 42 Manja Bouman CEO 42 OLYMPIA registry 42 ACNP 42 romidepsin 42 label multicenter Phase 42 ADA Scientific Sessions 42 Teriflunomide 42 Clinical Outcomes Utilizing Revascularization 42 Nonresidential Construction 42 vitro ADME 42 CUSTOM II 42 RTOG 42 Based Costing 41 LUPUS 41 ISTODAX ® 41 AGA Medical Nasdaq AGAM 41 Verona Pharma 41 oral Xeloda 41 Coronary Artery Calcium 41 NACFC 41 MADIT 41 Biocompatibility 41 Results Exceed Expectations 41 Quality Indicators 41 Clinical Oncology Annual Meeting 41 ACOMPLIA R 41 Mammography Screening 41 Vaxfectin R adjuvant 41 Antisoma plc 41 RIBBON 41 Peer Reviewed 41 subgroup analyzes 41 Secondary endpoints include 41 ACC AHA SCAI 41 ALB # 41 DEFER 41 Patient Satisfaction Survey 41 Hugues de Bantel 41 Alnylam #x# 41 Revises Guidance 41 Poniard Pharmaceuticals Announces 41 Aeolus Pharmaceuticals Announces 41 Trandolapril 41 TMC# C# 41 Shows Modest 41 RDEA 41 http:/www.vivus.com 41 Transcatheter Cardiovascular Therapeutics 41 Self Efficacy 41 SCAI Annual 41 Carotid Artery Stenting 41 RADIANT 41 EVA Extra Vehicular 41 NEUPREX R 41 Upward Revision 41 Backs FY# 41 Extended Duration 41 Semafore Pharmaceuticals 41 relapsing multiple sclerosis 41 Diet Linked 41 www.hematology.org 41 Protein Synthesis 41 Pharmacodynamics 41 UEGW 41 Molecular Mechanism 40 SERENADE 40 Therapeutic Intervention 40 coinfected patients 40 CELGENE 40 Digestive Disease Week DDW 40 Significant Improvements 40 STENT 40 ISPOR 40 Revises Q3 40 #nd Annual Meeting 40 Growth Exceeds Expectations 40 PREVAIL 40 Ragweed Allergy 40 Remains Flat 40 IASLC 40 #QF# 40 www.novelos.com 40 Affirms FY# 40 Glatiramer acetate 40 Philadelphia Chromosome Positive 40 Depressive Symptoms 40 Idenix Pharmaceuticals Reports 40 http:/www.hematology.org 40 Avastin bevacizumab 40 SGX Pharmaceuticals 40 CANCER SUPPORT 40 RENAL 40 STELLAR 40 Medical Materiel 40 Highlights Include 40 Acute Stroke 40 EuroPCR 40 Reaffirms FY 40 ACCLAIM 40 Clinical Oncologists 40 HyQ 40 Glucose Screening 40 CONSORT 40 Protein Linked 40 Kendle NASDAQ KNDL 40 Drilling Activity 40 Pharmacokinetic parameters 40 Rise Unexpectedly 40 Fibromyalgia Pain 40 HEART FAILURE 40 CANCER RESEARCH 39 AHA Scientific Sessions 39 Amgen NASDAQ AMGN 39 PSORIASIS 39 ACR ARHP 39 FDA Approves Drug 39 OSIR 39 radioimmunotherapy RIT 39 Bapineuzumab 39 Patent Reexamination 39 anti arrhythmic drug 39 REACH Registry 39 Functional Proteomics 39 Neurosearch 39 Antipsychotic Drug 39 nd Annual Meeting 39 catered Alpine chalet 39 patients coinfected 39 ONTARGET 39 Liver Disease AASLD 39 THE JOURNAL 39 Lancet Oncol 39 Breast Cancer Stem Cells 39 Patterson UTI Reports 39 EFNS 39 ClinicalTrials.gov Identifier NCT# 39 IFMarketStrategy 39 Fred Biltz 39 Lowers Q4 39 Helps Smokers Quit 39 FIBROMYALGIA 39 Final Appraisal Determination 39 Slashes FY# 39 CEHC 39 Helps Detect 39 Sees Positive 39 NicVAX TM 39 Endocrine Society #st 39 serologically active SLE 39 HUMAN GENOME SCIENCES 39 Reiterates Guidance 39 Plecanatide 39 SPIVA 39 Market Awaits 39 OVATURE trial 39 Dollar Pares Gains 39 Inc. Nasdaq HGSI 39 MULTIPLE MYELOMA 39 oral mucositis OM 39 BRITE 39 ALLEGRO 39 Slight Dip 39 Losses Deepen 38 Lymphoma Patients 38 Lowers 4Q 38 Arpida Ltd. 38 Strongly Linked 38 PRECISE 38 HALTS 38 Lowers 1Q 38 Vapor Intrusion 38 Investors Await Earnings 38 Successfully Concludes 38 BOLDER 38 Sensor Fusion 38 Urocidin ™ 38 Statistical Tables 38 ELCAP 38 ACR ARHP Annual 38 Significantly Strengthens 38 Milestone Achieved 38 Polyunsaturated Fatty Acids 38 Trading Volumes 38 ATTRACT 38 Seminar Focuses 38 EASD 38 convenient dosing regimen 38 Consolidation Continues 38 Mitotic 38 Novo Nordisk NYSE NVO 38 CIGNA CI 38 Q#IR 38 Therapeutic Monoclonal Antibodies 38 Previously Disclosed 38 Provides Updated 38 Orexigen Therapeutics OREX 38 CARDIOVASCULAR 38 Results Indicate 38 Delivers Solid 38 Left Atrial 38 JOURNAL OF 38 Tertiary Industry 38 Healthy Behaviors 38 CombAT study 38 Smarter Decisions 38 San Antonio Breast Cancer 38 Hematology ASH Annual Meeting 38 Managements Discussion 38 Hoji Alimi founder 38 DSEN 38 BLOSSOM 38 Swiss SVME PMI 38 ARVO 38 OVARIAN 38 Pentagon Counterintelligence Field 38 George Bakris 37 Adolescent Substance Abuse 37 Outpatient Physical Therapy 37 Oxford Biomedica 37 ViRexx Announces 37 Significant Improvement 37 Productivity Rises 37 ICON plc 37 Biocompatibles International 37 iloprost 37 ACEIs 37 ACADIA Pharmaceuticals 37 Chantix Champix 37 Chart Presentation 37 Small Vessel 37 SitePRO 37 Achieves Record Revenue 37 Critical Component 37 Amarin Corporation 37 Schaeffer Option 37 Fort Belvoir Va. SP# 37 Titan Pharmaceuticals 37 Revises Upward 37 Revises Second Quarter 37 Drops Sharply 37 Reaches Profitability 37 Decline Slows 37 Posttraumatic Stress 37 Trading Activity 37 CDDO 37 Upside Surprise 37 Economic Optimism 37 Cuts FY# 37 Scientists Unravel 37 Fell Sharply 37 Reaffirms Earnings 37 Asthma Treatment 37 DVT prophylaxis cholesterol 37 Backs FY# EPS 37 Longer Term 37 UTSW 37 Heska Announces 37 Gestational Diabetes 37 Neurology AAN 37 Psychological Effects 37 Scattered Storms 37 Creeps Higher 37 Logo http:/www.newscom.com/cgi-bin/prnh/#/Chai Garam 37 Ventiv Health 37 Brain Wiring 37 ELSO 37 Liver Disease 37 Results Reflect 37 Wrestling Wrap Up 37 Stronger Than Expected 37 antimicrobial susceptibility 37 Revised Downward 37 EGFR mutated 37 Clavis Pharma ASA 37 Anticoagulation 37 Medicure Announces 37 Data Awaited 37 transdermal estradiol gel 37 Clinical Microbiology 37 Bioquell 37 Sees Steady 37 Experts Convene 37 Innovium Announces 37 Adtegrity.com Reports 37 International Nasdaq CRAI 37 FREEDOMS 37 LUCENTIS 37 Share Repurchases 37 Largely Unchanged 37 imatinib resistance 37 Brookings Papers 37 Antimicrobial Agents 37 Informational Session 37 Crane Army Ammunition 37 Cognitive Abilities 37 Stock Repurchase 37 Hourly Earnings 37 LUNG CANCER 36 Bluechips Portfolio 36 Myelodysplastic Syndromes MDS 36 IFRS changeover 36 ENDO 36 Clinical Electrophysiology 36 Cash Dividend Declared 36 Digestive Disease Week 36 Live Attenuated 36 Improved Second Quarter 36 SENO 36 WYETH 36 Roars Ahead 36 Revises Q4 36 st Annual Meeting 36 th Interscience Conference 36 ACCOMPLISH 36 Computer Interfaces 36 Brain Functions 36 Activity Slows 36 BullMarket.com Examines 36 Child Neurology 36 ILLUSTRATE 36 Housing Starts Plunge 36 Pound Weakens 36 Brain Shrinkage 36 Achieves Record Quarterly 36 Hematology Meeting 36 Futures Slip 36 Trim Losses 36 Fifth Decennial International 36 Rapidly Evolving 36 Amicus Therapeutics Inc 36 Capacity Utilization Rate 36 Speakers Announced 36 LEVAQUIN 36 Alexion Pharmaceuticals Inc 36 May Have Peaked 36 Q1 Adj 36 Loan Delinquencies 36 Trend Toward 36 Gynecologic Oncologists 36 LYME DISEASE 36 Reaffirms FY# 36 Remains Weak 36 Iressa gefitinib 36 Quantify 36 ALZHEIMER 36 CABERNET 36 Revises Fourth Quarter 36 Clinical Oncology ASCO Annual 36 Aptivus R 36 Cribbage Wednesdays 36 ICON plc ICLR 36 Clinical Oncology ASCO 36 PROMETA protocols 36 Photocure ASA 36 Protein Folding 36 Consumer Borrowing Slows 36 Resource Utilization 36 AACR 36 AGAINST CANCER 36 relapsed refractory 36 Revised Upward 36 Highly Successful 36 Stocks Wobble 36 Mortgage Approvals 36 Edges Down 36 Residential Remodeling 36 RESIST 36 Blood Pressure Checks 36 Distributive Trade 36 ESMO 36 Traders Await 36 Lung Cancer 36 Medifast NYSE 36 Strengthens Balance Sheet 36 #-# Compliant 36 As Traders Await 36 Protein Profiling 36 fatty acid amide hydrolase 36 Biologic Agents 35 Reaffirms Outlook 35 Reaffirms Guidance 35 Rises Unexpectedly 35 Reiterates FY# 35 ValiRx 35 Adolescent Immunization 35 GENENTECH 35 Masimo PVI 35 Cognitively Impaired 35 Onconova Therapeutics Inc. 35 BLOOM 35 Up Modestly 35 Servicer Performance 35 AAO HNS 35 Rate ORR 35 Growing Importance 35 Report Assesses 35 Encision Reports 35 ENDEAVOR 35 Issued Interest Bearing 35 Approves Stock Repurchase 35 BIOSCIENCES 35 Moli# 35 trough FEV1 35 Evil Dead Remake 35 Authorizes Share Repurchase 35 ISM Manufacturing Index 35 Consumer Confidence Dips 35 Fairytale puppets 35 Announces Favorable 35 Machine Tool Orders 35 Reverse Engineering 35 Reaffirms Fiscal 35 Molecular Targets 35 Technological Advances 35 HFSA 35 Builder Confidence 35 Stress Testing 35 Continues Upward Trend 35 Q4 Adj 35 antithrombotic therapy 35 TA NIC 35 DDW 35 2nd edn 35 Posts Profitable 35 Neuro Oncology SNO 35 IPMN 35 Edges Lower 35 PROSTATE 35 Continues Decline 35 GLAXOSMITHKLINE 35 Ups Guidance 35 Improved Profitability 35 Breast Cancer Survivorship 35 Passive Smoking 35 CLINICAL 35 Shows Slight 35 Room C# 35 Restate Certain 35 Antibiotic Resistant Bacteria 35 Dips Slightly 35 Futures Tumble 35 Findings Reveal 35 Swiss Franc Gains 35 Reproducibility 35 Approves Share Repurchase 35 RESILIENT 35 Earlham Wellness 35 Announces Share Repurchases 35 NXY 35 Bullish Sentiment 35 Oncimmune 35 DBMD 35 Barnhardt Student 35 Intranasal Ketamine 35 American Urological Association 35 Hormone Levels 35 Preliminary Third Quarter 35 Meets Expectations 35 Broadly Lower 35 AACR NCI EORTC Molecular 35 PRELIM 35 ASH 35 Alturas exploration 35 Proves Successful 35 Eurozone Manufacturing PMI 35 Investors Await 35 Option Skews Relatively 35 QOPI 35 HORIZON 35 Early Learners 35 Sees Modest 35 Eurozone Purchasing Managers 35 Stocks Narrowly Mixed 35 Prompts Changes 35 Cardiovascular Anesthesiologists 35 empirically derived 35 Neck Cancer 35 Stroke Prevention 35 Seasonal Pattern 35 Boosts Share Buyback 35 CARDIAC 35 Anticipates Strong 35 Rally Loses Steam 35 Hematology ASH 35 Rasilamlo 35 Bone Fractures 35 RECOVER 35 ad hoc querying 35 revises FY# 34 Margin Expansion 34 Interventions SCAI 34 ERSPC 34 Biogeochemical 34 NOVARTIS 34 Upward Momentum 34 DESC Fort Belvoir 34 Significant Increase 34 Regularly Scheduled 34 invivodata 34 Combating Counterfeit Drugs 34 Stays Strong 34 Jobless Claims Climb 34 genotype phenotype 34 QMed 34 Nears Launch 34 commercialize Qutenza 34 Cautionary Factors 34 Relapsing remitting 34 Helps Identify 34 Stocks Waver 34 Data Disappoint 34 Report Sheds Light 34 Hurco Reports 34 Mass Layoff 34 toreflect 34 HEPATITIS 34 Candler Wellness 34 Continues Slide 34 Modifiable 34 Homebuilder Confidence 34 EUROGIN 34 ADA EASD 34 Ark Therapeutics 34 Beats Zacks 34 CERVICAL 34 EULAR 34 Biosensor Technology 34 Reaffirms Full 34 HEART HEALTH 34 Amends Stockholder Rights 34 Could Revolutionize 34 Investors Await Fed 34 Pending Acquisition 34 Remains Sluggish 34 Specialty Injectable Pharmaceuticals 34 Continuing Jobless Claims 34 Delivers Strong 34 Gainful 34 Releases Third Quarter 34 Leading Indicators Index 34 COGENT 34 Pandemic Response 34 DIAGNOSTIC 34 Takes Breather 34 Dollar Sags 34 Cognitive Ability 34 Smoking Cessation 34 K DOQI 34 Sleep Patterns 34 League Against Rheumatism 34 Detailed 34 Demographic Trends 34 Strategic Repositioning 34 Unexpectedly Drops 34 Imaging Techniques 34 BMES 34 Va. SP# 34 Continues Upward 34 Fy# 34 Rise Modestly 34 NULCF 34 SMOKING CESSATION 34 ERA EDTA 34 Amid Weak 34 Down Sharply 34 Nasdaq Notice Regarding 34 Revises Full 34 Techs Lead 34 Backs FY# Adj 34 Drop Sharply 34 Isiah Fredericks Community 34 4Q Profit Slides 34 Unexpectedly Rise 34 H#N# Vaccination Clinics 34 Rises Sharply 34 Balance Sheet Cash Flow 34 Weaker Than Expected 34 Upcoming Releases 34 Virtually Unchanged 34 Psychopharmacology 34 Sentix Investor Confidence 33 MULTIPLE SCLEROSIS 33 TREATMENT OPTIONS 33 Doubles Size 33 Pulmonary Hypertension Association 33 Rally Falters 33 Stagnates 33 Yen Crosses 33 XR NTX 33 Rarer Cancers Forum 33 Files Audited 33 arebased 33 Chartbook 33 Issues Resolved 33 CONQUER 33 ARTHRITIS 33 Credit Card Defaults 33 Flexpoint Announces 33 Confidence Slips 33 Broadens Product 33 Stocks Stabilize 33 Antidepressants Linked 33 Upward revision 33 Sales Disappoint 33 Proposed Revisions 33 FOR BREAST CANCER 33 Fetal Medicine Foundation 33 Attracts Attention 33 AANS 33 Recommends Changes 33 Holds Steady 33 Initiative K DOQI 33 endometrial thickening 33 SCHERING PLOUGH 33 Personal Consumption 33 Maidu Community 33 Sees Slight 33 Clinical Oncology 33 DANCE CONCERT 33 BREAST CANCER 33 ALLEGATIONS AGAINST 33 Focused Instruction 33 Margin Improvement 33 Locomotor 33 Leading Indicators 33 Closes Previously Announced 33 Rise Dramatically 33 PRAI 33 Holding Steady 33 Microfluidic Devices 33 CHARISMA 33 Prochymal Chondrogen 33 LEUKEMIA 33 Boosts Guidance 33 COMPARE 33 lifts FY# EPS 33 ISM Non Mfg 33 SYMMETRY 33 Woes Weigh 33 Modest Increase 33 Vicor Technologies Announces 33 Approves Stock Buyback 33 Cancer MASCC 33 Smart Grid Deployment 33 Exceeds Guidance 33 ASCB 33 Markets Await 33 - Aarkstore Enterprise [002] 33 Improves Slightly 33 Boosts Profit 33 instrument SHORT TERM 33 Data Disappoints 33 Slower Than Expected 33 Implant Sciences Announces 33 Brengle Terrace Recreation 33 Experimental Biology EB 33 Calgon Carbon Announces 33 Formulates 32 Flexible Electronics 32 NWCI 32 Calcium Intake 32 Announces Share Buyback 32 Williston Basin Bakken 32 Homebuilder Stocks 32 COMMUNITY ASSOCIATION 32 treat nicotine addiction 32 Revises Fiscal 32 POC Testing 32 MDCI 32 Marginally Higher 32 Disaster Readiness 32 Interest Rate Speculation 32 Active Regions 32 Hematology 32 Productivity Growth Slows 32 Credit Card Delinquencies 32 Raises Full 32 Proved Reserve 32 Consumer Confidence Slips 32 MEDTRONIC 32 Clinical Pharmacy 32 Van Matre Duplicate Bridge 32 Shift Towards 32 Position Squaring 32 Fraud Schemes 32 AGENDA 32 -ECKSTEIN 32 Underpins 32 Scorecarding 32 Clinical Endocrinologists AACE 32 Christiansburg Recreation 32 Rates Remain 32 CANCER TREATMENT 32 NORTH HALL 32 Discount Fundamental Strength 32 Vitamin D Supplementation 32 Healthnostics Announces 32 Dukoral ® 32 Bearish Trend 32 Insulin Pump Therapy 32 Barely Changed 32 Lower Than Expected 32 Jobless Claims Increase 32 Consumer Sentiment Improves 32 Restate Financials 32 AADE 32 Mountain Caregiver Resource 32 Data De Duplication 32 FASB IASB 32 Growth Slowed 32 Rises Slightly 32 GWTG 32 FOXCROFT 32 Grains Soybeans Retreat 32 SEACOAST 32 Morpace Reports 32 CTRC AACR 32 Drug Seizure 32 Aggressive Growth 32 GRAVITAS 32 OVARIAN CANCER 32 Karate Classes 32 Finalizes Plans 32 Biweekly 32 Preclinical Platform 32 Above Estimates 32 Reduce Expenses